A red blood cell distribution width (RDW) test is an important part of a complete blood count (CBC) test. It measures the range of red blood cell sizes in the body. A high RDW result can indicate anemia, inflammation, or other health conditions. In this article, we will discuss the meaning of a high RDW result, and its potential implications.
RDW is a measure of the range of red blood cell sizes in the body. It is usually expressed as a percentage. The size of red blood cells can vary from person to person, but a high RDW result indicates that the size of the red blood cells is unusually wide.
A high RDW result can indicate a number of possible health conditions. It can be a sign of anemia, which is a condition in which the body does not have enough healthy red blood cells. It can also be a sign of inflammation, which is a response of the body to infection or injury. In some cases, it can be a sign of a vitamin B12 or folate deficiency.
If a high RDW result is found on a CBC test, further tests may be needed to diagnose the cause. These tests may include a ferritin test to check for anemia, a C-reactive protein test to check for inflammation, and a vitamin B12 and folate test to check for deficiencies.
The treatment for a high RDW result will depend on the underlying cause. If the cause is anemia, iron supplements may be prescribed to increase the number of healthy red blood cells in the body. If the cause is inflammation, anti-inflammatory medication may be prescribed. If the cause is a vitamin B12 or folate deficiency, supplements may be prescribed.
A high RDW result can be a sign of several different health conditions. It is important to discuss any abnormal results with a doctor, who can order further tests to diagnose the cause. Depending on the underlying cause, treatment may involve iron supplements, anti-inflammatory medication, or vitamin B12 or folate supplements.
1.
The use of biomarkers in the treatment of breast lumps is at a crossroads.
2.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
3.
How Do Younger People Fare With Stool Tests for CRC Screening?
4.
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL
5.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
1.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
2.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
3.
Introduction to Immune Thrombocytopenic Purpura
4.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
5.
The Different Types of Cysts and Why They Occur: Insights from a Dermatologist
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
2.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
3.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation